Eklund, Martin
Grönberg, Henrik
Nordström, Tobias
Article History
First Online: 10 May 2016
Competing interests
: H.G. owns stock in Procant and, via this company, is co-owner of five prostate cancer diagnostic-related patents pending, has patent applications licensed to Thermo Fisher Scientific, and might receive royalties from sales related to these patents. M.E. is named as a co-inventor on four of these five patent applications. M.E. also owns stock in Genetta Soft and EKED Consulting. Karolinska Institutet collaborates with Thermo Fisher Scientific in developing the technology for STHLM3.